Albion News

Astronautx lab image.jpg
AstronauTx Ltd, a biotech company developing new medicines designed to restore the normal behaviour of astrocytes for the treatment of Alzheimer’s disease, Dementia and other neurodegenerative diseases, today announces £1 million investment from the UCL Technology Fund to enable the development of translatable biomarkers for their drug discovery programs. read more
Albion News Spring 2020
  The magazine aims to give you an overview of Albions' recent developments, investment sector insight from our partners and a performance update on our VCTs. We are also delighted to invite all Charity Trustees to the OLIM Investment Managers Charity Conference To view the magazine, please click here  read more
Nadine Torbey - Top 50 UK Female tech investors
Every year, WoW (Women of Wearables) release a different Top Women list and this year they focussed on female investors in the UK tech space. Albion is delighted to see that our tech investment manager Nadine Torbey appears in the list for the first time. For the full story click here read more
Investment of the Year WINNER 2019 2.jpg
SEHTA announced the winners of our 2019 MedTech Business Awards and UCL Technology Fund investments Echopoint and ODIN won in two categories. Echopoint Medical won the Investment of the Year Award for their achievements in receiving equity investment from the UCL Technology Fund (managed by AlbionVC in partnership with UCLB) and Parkwalk Advisors as well as significant InnovateUK grants to develop their iKOr platform. ODIN Vision won the Start-Up of the Year Award as a leading start-up in a new era of artificial intelligence in endoscopy. Congratulations to all at Echopoint and ODIN.  To view... read more
Bravo Inns
Bravo was founded in May 2007 by Ken Buckley and Philip Dearden, together with financial support from Albion Capital.  In early 2007, Ken, Phil and Albion successfully exited The Bold Pub Company, an estate of 30 pubs. The Bravo estate currently comprises 44 predominantly freehold and well-invested pubs trading under the successful operator managed model.  Profits have increased from £1.9m in 2017 to in excess of £2.6m today due to selective site acquisitions and growth capital investment. Following completion of the sale, Ken Buckley will continue as a consultant to the business and the... read more
Fishmongers' Hall.jpg
Many thanks to all those that joined us at The Fishmongers' Hall for another very successful seminar Some of the slides from this event are available on request. Please contact read more
Congratulations to Mike Parsons, Chairman of Albion Care Communities, who won the 'Non Executive Director 2019' at the HealthInvestor Power Fifty Awards 2019.  The HealthInvestor Power Fifty NED prize is given to an individual who has shown themselves to be a dynamic, must-have non-executive director or chairman of a health and social care company by being the perfect foil to the executive teams and an invaluable font of knowledge. Mike founded Barchester Healthcare and was its Group CEO between 1992 and 2013. During this period Barchester grew rapidly, both organically and through... read more
Lancashire-based ELE provides highly specialised technology, including advanced robotics, to precision engineer components for the aerospace, power and automotive sectors for clients including GE, Rolls-Royce and Siemens. In its latest financial year, ELE generated revenues of almost £14 million, and currently employs more than 180 people from its facilities in Colne, Lancashire, and Trencin, Slovakia. Robert Whitby-Smith, Partner, Albion, says: “As a long-term supporter of ELE, we are delighted to have achieved a total return of 4x cost for our investors and that ELE has found a strong... read more
We are delighted to announce that Siemens AG has announced plans to acquire Process Systems Enterprise (PSE), the leading supplier of Advanced Process Modelling (APM) software and services.  PSE built a category leading industrial software business, and the excellent return is driven by a combination of strong growth (10X software revenue since AlbionVC’s initial investment) with top decile capital efficiency - little more than the £2m invested by AlbionVC raised by the company over its lifetime. The exit represents a return of c.10x for the Albion VCTs. Process Systems Enterprise (PSE), the... read more
Abcodia will establish offices in the Wuxi International Life Science Innovation Campus (“I·Campus”), which has been created by WND and AstraZeneca. I·Campus is an innovation incubation platform offering services in R&D, commercialization and professional services in the life science industry for domestic and foreign companies looking to establish or expand their presence in China. From this location, Abcodia will work collaboratively with AstraZeneca and other partners in a life science innovative ecosystem to establish its ovarian cancer screening technology in China.   China represents... read more